In this project we will develop new biomarkers and algorithms for use in epidemiological studies of women's reproductive health. Methods will be developed for assessing pituitary function and early fetal loss by the identification of different molecular forms of the secreted pituitary and trophoblastic gonadotropins. Practical assays will be developed for detecting the corresponding metabolites that are excreted in urine samples. Algorithms for assessing abnormalities of menstrual function in epidemiological field studies will be developed to utilize the biomarker data which can be generated with existing urinary assays. These algorithms will be utilized for identification of the effects of environmental exposure on the pre-ovulatory and peri-ovulatory phases of the menstrual cycle, when perturbations of the ovarian function may lead to decreased fertility. Trophoblastic function will be characterized in studies of the ovarian response to healthy and failing embryos. The pattern of ovarian response will be studied in relation to the normalcy of trophoblastic support in the peri-implantation period. Clinical research studies will provide basic information for identification of new biomarkers, for validation of assay methods, and for testing algorithms. All new tests will be applied to urine samples which have been collected and analyzed in previous epidemiological and toxicologic studies.

Project Start
1999-04-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
13
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Napimoga, M H; Rocha, E P; Trindade-da-Silva, C A et al. (2018) Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption. J Periodontal Res 53:743-749
Blöcher, René; Wagner, Karen M; Gopireddy, Raghavender R et al. (2018) Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain. J Med Chem 61:3541-3550
Hao, Lei; Kearns, Jamie; Scott, Sheyenne et al. (2018) Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther 365:467-475
Yang, Yang-Ming; Sun, Dong; Kandhi, Sharath et al. (2018) Estrogen-dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation. Proc Natl Acad Sci U S A 115:613-618
Zheng, Jing; Chen, Juan; Zou, Xiaohan et al. (2018) Saikosaponin d causes apoptotic death of cultured neocortical neurons by increasing membrane permeability and elevating intracellular Ca2+ concentration. Neurotoxicology 70:112-121
Cui, Xiping; Vasylieva, Natalia; Shen, Ding et al. (2018) Biotinylated single-chain variable fragment-based enzyme-linked immunosorbent assay for glycocholic acid. Analyst 143:2057-2065

Showing the most recent 10 out of 1149 publications